Carbidopa and Levodopa Enteral Suspension and Ramucirumab Intravenous
Determining the interaction of Carbidopa and Levodopa Enteral Suspension and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Enteral Suspension-Ranexa
- Carbidopa and Levodopa Enteral Suspension-Ranibizumab
- Carbidopa and Levodopa Enteral Suspension-Ranibizumab Intraocular
- Carbidopa and Levodopa Enteral Suspension-Ranibizumab ophthalmic
- Carbidopa and Levodopa Enteral Suspension-Ranitidine
- Carbidopa and Levodopa Enteral Suspension-Ranitidine Capsule
- Ramucirumab Intravenous-Carbidopa and Levodopa Extended-Release Capsules
- Ramucirumab Intravenous-Carbidopa and Levodopa Extended-Release Tablets
- Ramucirumab Intravenous-Carbidopa and Levodopa ODT
- Ramucirumab Intravenous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Ramucirumab Intravenous-Carbidopa and levodopa Route Not Applicable
- Ramucirumab Intravenous-Carbidopa and Levodopa Tablets